Unique ID issued by UMIN | UMIN000036879 |
---|---|
Receipt number | R000042025 |
Scientific Title | Therapeutic ethanol lock therapy to improve the success rate of treatment in Catheter Related Blood Stream Infections |
Date of disclosure of the study information | 2019/05/29 |
Last modified on | 2023/11/30 23:53:12 |
Therapeutic Ethanol Lock Therapy to improve the success rate of treatment in Catheter Related Blood Stream Infections
Keio-ELT2
Therapeutic ethanol lock therapy to improve the success rate of treatment in Catheter Related Blood Stream Infections
Keio-ELT2
Japan |
Catheter Related Blood Stream Infection; CRBSI
Not applicable | Adult | Child |
Others
NO
The principal objective of this trial is to evaluate the overall effectiveness of the ELT on CRBSI. The secondary objective of this trial is to evaluate the effectiveness of the ELT on each bacteria causing CRBSI.
Efficacy
Rate of successful preservation of the CVC catheter after each CRBSI event (success is defined as the affected catheter is safe to use at 4 weeks later to the initiation of the ELT to CRBSI without recurrence of CRBSI)
Occurrence rate of CRBSI.
Successful rate to achieve of the negative blood culture.
Relativity of each bacteria causing CRBSI and patients's background or success rate of preservation.
Number of times to perform ELT until the catheter required replacement.
Other events related to the catheter such as tunnel infection, complicated infection or breakage.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
NO
NO
1
Treatment
Maneuver |
Perform the catheter lock technic using ethanol for 7days, once a day after the definitive diagnosis of CRBSI was made.
Not applicable |
Not applicable |
Male and Female
Those who meets two conditions listed below are eligible to this trial
1. the patient has an implanted CVC catheter for long term use.
The catheter includes but not limited to
BrovIac Catheter
Hickman Catheter
Silascon catheter
Implanted CV port.
2. Their doctor thinks the patient requires preservation of the catheter when treating the CRBSI.
Those who meet these conditions are excluded from the trial.
1. the catheter is not made of silicon
2. the patient has allergy to alcohol
3. the patient is pregnant
4. the patient is breastfeeding
5. the patient does not require CVC preservation therapy
6. the patient or the patient guardians do not consent to the trial
7. any patients whose doctor thinks is not eligible.
30
1st name | Akihiro |
Middle name | |
Last name | Fujino |
Keio University
School of medicine, Department of Pediatric Surgery
160-8582
35 Shinanomachi, Shinjuku, Tokyo, Japan
03-5363-3024
a.fujino@keio.jp
1st name | Mototoshi |
Middle name | |
Last name | Kato |
Keio University
School of medicine, Department of Pediatric Surgery
160-8582
35 Shinanomachi, Shinjuku, Tokyo, Japan
03-5363-3024
mototoshi77@keio.jp
Keio University
Funded by the primary organization
Other
Keio University School of Medicine IRB
35 Shinanomachi, Shinjuku, Tokyo, Japan
03-3353-1211 Ext;62014
med-rinri-jimu@adst.keio.ac.jp
NO
2019 | Year | 05 | Month | 29 | Day |
Unpublished
Enrolling by invitation
2019 | Year | 04 | Month | 04 | Day |
2019 | Year | 05 | Month | 28 | Day |
2019 | Year | 05 | Month | 29 | Day |
2024 | Year | 05 | Month | 28 | Day |
2019 | Year | 05 | Month | 28 | Day |
2023 | Year | 11 | Month | 30 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042025
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |